Clinical study of GLP-1 receptor agonist (Exenatide) for type 2 diabetes patients with diabetic nephropathy
Not Applicable
Recruiting
- Conditions
- type 2 diabetes
- Registration Number
- JPRN-UMIN000037106
- Lead Sponsor
- Kagawa University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who fall under any of the following are excluded from this clinical study. 1) Patients who fall under the contraindication for GLP-1 receptor agonist 2) Patients participating in other clinical research 3) Pregnant women, pregnant women, lactating women or women who may have pregnancy 4) Patients with other serious complications 5) Patients judged to be unsuitable as a target by the judgment of other doctors
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method